Document is current

Any future updates will be listed below

Anti-PD-L1 antibody ASC22 in combination with a histone deacetylase inhibitor chidamide as a “shock and kill” strategy for ART-free virological control: a phase II single-arm study

Crossref DOI link: https://doi.org/10.1038/s41392-024-01943-9

Published Online: 2024-09-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark